Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2015-02-27 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement dated February 27, 2015, titled 'Total Voting Rights Announcement according to Article 26a of the WpHG'. It explicitly states the total number of voting rights (131,733,876) after an increase due to stock option exercise. This type of announcement, detailing changes in the total number of shares or voting rights, aligns best with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports on the current voting structure, even if it's not the final result of a specific vote, but rather a mandatory disclosure regarding the total capital structure affecting voting power. It is not a full report (10-K, IR), nor a dividend notice (DIV), nor a director's dealing (DIRS). Given the specific nature of reporting total voting rights, DVA is the most precise fit among the options.
2015-02-27 English
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (1372 chars) titled 'Evotec AG: Release according to Article 26a of the WpHG' and specifically mentions 'Total Voting Rights Announcement'. It states the total number of voting rights as of the end of January 2015. This content directly relates to changes in voting rights or share capital structure, but it is not a comprehensive report. Since it is a specific announcement regarding voting rights, it fits best under the category related to voting rights or capital changes. Given the options, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for an announcement detailing the total number of voting rights, even if it's not the final result of a specific vote, as it pertains to the underlying rights structure. It is too specific for the general 'RNS' fallback.
2015-01-30 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 100% confidence The document is very short (2870 characters) and its primary purpose is to announce the future disclosure dates for several financial reports, including the 'Annual financial report', 'Financial report of the group (half-year/Q2)', and various quarterly reports. It explicitly states that these reports 'shall be disclosed' on future dates and provides links to where they will be available. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement detailing the publication of other reports classifies as a Report Publication Announcement (RPA).
2015-01-22 English
Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme
Regulatory Filings Classification · 100% confidence The document is a press release dated January 19, 2015, announcing a research collaboration between Evotec AG and C4X Discovery Holdings plc regarding drug discovery for stress-related addictive disorders. It contains standard press release formatting, mentions 'DGAP-News', and discusses business developments rather than reporting periodic financial results (like 10-K or IR), management changes (MANG), or shareholder votes (DVA). Since it is a general corporate announcement that doesn't fit the highly specific categories like ER, IR, or CAP, it falls best under the general regulatory/news announcement category, which is RNS (Regulatory Filings) as per the definition provided for miscellaneous filings.
2015-01-19 English
Evotec achieves further milestones in TargetAD collaboration with Janssen
Regulatory Filings Classification · 99% confidence The document is a press release dated January 15, 2015, announcing that Evotec AG achieved milestones in its TargetAD collaboration with Janssen Pharmaceuticals. It details progress, mentions financial recognition in FY 2014, and includes standard company boilerplate and forward-looking statements. This type of announcement, which communicates specific operational or partnership progress outside of mandated periodic financial reports (like 10-K or IR), is typically classified as a general corporate news release. Since it is not a formal Earnings Release (ER), a Capital/Financing Update (CAP), or a Director's Dealing (DIRS), and it is not explicitly announcing the publication of a major report (RPA), the most appropriate general category for this type of corporate update, especially when disseminated via services like DGAP, is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory announcements not covered by more specific codes.
2015-01-15 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains multiple sections detailing 'Notification of voting rights pursuant to Art. 25, Sec. 1 WpHG'. This clearly indicates a filing related to changes in shareholder voting power thresholds, which aligns directly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a regulatory announcement, DVA is a more specific category than the general RNS fallback.
2015-01-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.